Abstract
DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.
| Original language | English |
|---|---|
| Pages (from-to) | 1512-1514 |
| Number of pages | 3 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 51 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2007 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
Cite this
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci. / Hong, Seong Geun; Moland, Ellen Smith; Wickman, Paul A.; Black, Jennifer A.; Hossain, Ashfaque; Hanson, Nancy D.; Thomson, Kenneth S.
In: Antimicrobial Agents and Chemotherapy, Vol. 51, No. 4, 04.2007, p. 1512-1514.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci
AU - Hong, Seong Geun
AU - Moland, Ellen Smith
AU - Wickman, Paul A.
AU - Black, Jennifer A.
AU - Hossain, Ashfaque
AU - Hanson, Nancy D.
AU - Thomson, Kenneth S.
PY - 2007/4
Y1 - 2007/4
N2 - DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.
AB - DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.
UR - http://www.scopus.com/inward/record.url?scp=34247141317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247141317&partnerID=8YFLogxK
U2 - 10.1128/AAC.00959-06
DO - 10.1128/AAC.00959-06
M3 - Article
C2 - 17220419
AN - SCOPUS:34247141317
VL - 51
SP - 1512
EP - 1514
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
SN - 0066-4804
IS - 4
ER -